Ottobock SE & Co. KGaA (ETR:OBCK)

Market Cap	3.52B
Revenue (ttm)	1.69B +5.4%
Net Income	91.80M +96.4%
EPS	n/a
Shares Out	63.99M
PE Ratio	38.34
Forward PE	18.34
Dividend	0.97 (1.77%)
Ex-Dividend Date	May 20, 2026

Volume	14,163
Average Volume	33,411
Open	55.20
Previous Close	55.00
Day's Range	54.00 - 56.10
52-Week Range	45.56 - 76.35
Beta	n/a
RSI	45.32
Earnings Date	May 6, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 10,365
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: OBCK

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.